Compare SaaS Products

Compare up to 4 software products side by side. Find the best solution for your business.

Add Products to Compare

2 of 4 products selected

Feature
Raycaster
Raycaster Biotech
ReactWise
ReactWise Biotech
Rating
3.0
3.8
Reviews 4 10
Category Biotech Biotech
Description

Raycaster is the enterprise AI engine for life sciences. From speeding up regulatory approval and manufacturing tech transfer, Raycaster advances the Industry 4.0 initiatives with world's leading life sciences companies.

Our Mission: We aim to accelerate and automate chemical process development by equipping wet-lab chemists with the power of data-driven optimization and robotic execution of experiments. The Problem: The discovery of novel pharmaceuticals is one of our most important weapons in fighting disease. However, the drug development pipeline is often held up for many months during the design of chemical processes to manufacture these drugs at scale, delaying FDA trials and lengthening the time until drug launch. Designing chemical processes involves the identification of suitable parameters such as catalyst/temperature/solvent. Currently process development is often done via tedious trial-and-error experimentation (slow) or exhaustive screening (expensive and wasteful). Our Approach: In our research, we have developed algorithms for chemical process optimization, which leverage transfer learning and Bayesian optimization. We validated the algorithms in the wet lab, showing an up to 95% reduction in required experiments and cost compared to exhaustive screening. We have made our approaches accessible to chemists through our user-friendly no-code software platform and to automated laboratory equipment with our API.

Website https://raycaster.ai https://www.reactwise.com/
Positives
"Love the integration options. Works perfectly with our stack."
Kathleen Schiller - 5/5
"Has significantly improved our team's productivity."
Emerald Towne - 5/5
Negatives
"Not quite what we expected. Lacking some key features."
Prof. Gaetano Labadie - 1/5
"Performance issues during peak usage times."
Gretchen Gusikowski - 1/5
Details View Full Review → View Full Review →